Biotech · Private company
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Track this companyFree. Adds K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ZN-c3Phase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
- ZN-d5Phase 2 · AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- ZN-d5 ZN-c3Phase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)PHASE1_PHASE2 · TERMINATED · started Dec 1, 2022ClinicalTrials.gov NCT05682170 · fetched Nov 12, 2026
- Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) AmyloidosisPHASE1_PHASE2 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT05199337 · fetched Nov 12, 2026